Dimer formation of receptor activator of nuclear factor κB induces incomplete osteoclast formation
Katsuya Iwamoto(Kumamoto University), Toshio Suda(Chinese Academy of Sciences), Yumi Sawatani(Kumamoto University), Kana Nomiyama(Keio University), Naobumi Hosogane(Keio University), Isao Hamaguchi(National Institute of Infectious Diseases), Takeshi Miyamoto(Kumamoto Health Science University), Katsumasa Takagi(Yokosuka Kyosai Hospital), Masamichi Takami(Showa University)
Cited by 22
Related Papers
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
|Proceedings of the National Academy of Sciences|1998|4.3k
Tumor Necrosis Factor α Stimulates Osteoclast Differentiation by a Mechanism Independent of the Odf/Rankl–Rank Interaction
|The Journal of Experimental Medicine|2000|1.3k
Identity of Osteoclastogenesis Inhibitory Factor (OCIF) and Osteoprotegerin (OPG): A Mechanism by which OPG/OCIF Inhibits Osteoclastogenesis<i>in Vitro</i><sup>1</sup>
|Endocrinology|1998|1.2k
DC-STAMP is essential for cell–cell fusion in osteoclasts and foreign body giant cells
|The Journal of Experimental Medicine|2005|899
Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis
|Cell Metabolism|2006|771